Epidemiological trends of invasive Streptococcus pyogenes infections in Catalonia, 2022–2024: a two-year analysis - Scorecard - MDSpire

Epidemiological trends of invasive Streptococcus pyogenes infections in Catalonia, 2022–2024: a two-year analysis

  • By

  • Marta Martorell

  • Aurora Sabrià

  • Victoria Rello-Saltor

  • Antoni Soriano-Arandes

  • Damaris Berbel

  • Cristina Esteva

  • M. Dolors Estivill

  • Silvia Capilla

  • Teresa Llovet

  • Inés Valle

  • F. Xavier Queralt

  • Mireia Rajadell

  • M. Dolores Quesada

  • Maria Navarro

  • Frederic Gomez-Bertomeu

  • Yuliya Poliakova

  • Alba Bellés

  • Laura Solaz

  • Ana Siverio

  • Guillem Vidal

  • Mar Olga Perez-Moreno

  • Claudia Miralles

  • Elisabet Folch

  • Natàlia Roca

  • Mariana Fernandez-Pittol

  • Jordi Duran

  • Pep Ballester

  • Carme Gallés

  • Belén Viñado

  • Sonia Broner

  • Jacobo Mendioroz

  • Pilar Ciruela

  • June 18, 2026

  • 0 min

Share

Clinical Scorecard: Trends in Invasive Streptococcus pyogenes Infections in Catalonia: A Two-Year Epidemiological Study from 2022 to 2024

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationYoung children, older adults, and individuals with underlying conditions such as diabetes, cancer, and cardiovascular disease.
Care Setting

Key Highlights

  • Enhanced surveillance for iGAS was implemented in Catalonia in October 2022 in response to increased cases.

Guideline-Based Recommendations

Diagnosis

    Management

    • Notify territorial epidemiological surveillance units for contact tracing and antibiotic prophylaxis.
    • Consider specific antibiotics based on local guidelines.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Clinical outcomes include hospitalization and ICU admission; mortality defined as all-cause death within 30 days of diagnosis. Consider specific antibiotic treatments.

        Clinical Best Practices

        • Conduct enhanced surveillance for iGAS cases.
        • Implement contact tracing and assess the need for antibiotic prophylaxis in high-risk contacts.
        • Consider underlying risk factors when assessing patients.
        • Monitor for respiratory viral coinfections.

        Related Resources & Content

        Original Source(s)

        Epidemiological trends of invasive Streptococcus pyogenes infections in Catalonia, 2022–2024: a two-year analysis

        • by Marta Martorell, Aurora Sabrià, Victoria Rello-Saltor, Antoni Soriano-Arandes, Damaris Berbel, Cristina Esteva, M. Dolors Estivill, Silvia Capilla, Teresa Llovet, Inés Valle, F. Xavier Queralt, Mireia Rajadell, M. Dolores Quesada, Maria Navarro, Frederic Gomez-Bertomeu, Yuliya Poliakova, Alba Bellés, Laura Solaz, Ana Siverio, Guillem Vidal, Mar Olga Perez-Moreno, Claudia Miralles, Elisabet Folch, Natàlia Roca, Mariana Fernandez-Pittol, Jordi Duran, Pep Ballester, Carme Gallés, Belén Viñado, Sonia Broner, Jacobo Mendioroz, Pilar Ciruela

        • June 18, 2026

        Related Content

        Side Effects: The Hidden Variable

        The partner in the next room, the hormone in the blister pack, the cat on the couch, the minute-long chair stand. Several new studies suggest the factor shaping outcomes may be the one clinicians aren’t routinely measuring.

        Influenza Activity and Estimated Vaccine Effectiveness During the 2025-2026 Influenza Season

        The Open Syndrome Definition as a Machine-Readable Standard for Public Health: Design and Implementation Study